Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-13 · accession 0001415889-24-023467 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-13 | AMPH | Zhang Jack Y. | CEO, CSO, Dir, 10% | M - OptEx | $14.69 | +100.0K | 2.63M | +4% | +$1.47M |
| D | 2024-09-16 | 2024-09-13 | AMPH | Zhang Jack Y. | CEO, CSO, Dir, 10% | M - OptEx | $0.00 | -100.0K | 290.5K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-13 | M | A | 100,000 | $14.69 | 2,633,554 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-09-13 | M | D | 100,000 | $0.00 | 290,477 | D | $14.69 · — to 2025-03-16 | 100,000 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |